Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 21 (4) , 223-226
Abstract
There are few studies in the literature investigating pituitary size at an age consistent with the menopause and the influence of estrogen replacement therapy on pituitary height. We therefore evaluated the effect of estrogen on pituitary size, prolactin and thyroid-stimulating hormone (TSH) levels in menopausal women. Sixty-nine women were evaluated, 47 using estrogen and 22 controls. The measure of pituitary height was obtained from magnetic resonance imaging. Hormone evaluation did not show a statistically significant difference in mean (±standard deviation) prolactin level between the group using estrogen (7.6 ± 6.4 ng/ml) and controls (5.1 ± 3.4 ng/ml; p = 0.15), yet mean TSH level was significantly higher in the treated group (1.9 ± 1.5 vs. 1.2 ± 0.9 μU/ml; p = 0.03). Mean pituitary height in the estrogen-treated group (5.2 ± 1.4 mm) was greater than in the controls (4.4 ± 1.4 mm; p = 0.04). However, when such potential confounders as age, prolactin and TSH levels, treatment and duration of estrogen exposure were considered, the magnitude of difference did not attain significance. In conclusion, estrogen may play a role in pituitary size, since a mean difference in pituitary height, estimated as 0.78 mm, was detected between the groups in favor of the estrogen-treated group. This suggestion can be investigated in further studies.Keywords
This publication has 18 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Transforming Growth Factor-β Regulation of Estradiol-Induced ProlactinomasFrontiers in Neuroendocrinology, 2001
- Increased Need for Thyroxine in Women with Hypothyroidism during Estrogen TherapyNew England Journal of Medicine, 2001
- Analysis of indirect signs of microprolactinoma at MR imagingEuropean Journal of Radiology, 1999
- Estrogen Action in the Regulation of Cell Proliferation, Cell Survival, and Tumorigenesis in the Rat Anterior Pituitary GlandEndocrine, 1999
- Pituitary Enlargement on Magnetic Resonance Imaging in Congenital HypothyroidismArchives of Pediatrics & Adolescent Medicine, 1996
- Progestin Effects on Prolactin Secretion and on Immunoreactive Prolactin Cells in Estradiol-Treated Ovariectomized RatsHormone and Metabolic Research, 1993
- The Pituitary Gland in Pregnancy: A Clinicopathologic and Immunohistochemical Study of 69 CasesMayo Clinic Proceedings, 1990
- Height of Normal Pituitary Gland on MR ImagingJournal of Computer Assisted Tomography, 1990
- Effects of Estrogen on the Human Pituitary: A Clinicopathologic StudyMayo Clinic Proceedings, 1989